Literature DB >> 16943638

Physicochemical characteristics of commercial lactases relevant to their application in the alleviation of lactose intolerance.

S O'Connell1, G Walsh.   

Abstract

Selected microbial lactases are used to treat lactose intolerance. A series of experiments were carried out in vitro in order to determine the likely relative suitability of four major commercial lactase products used in this regard. The lactases displayed between 55 and 61% of maximum activity at 37 degrees C and significant activity between pH 3.0 and 6.5. They retained between 0 and 65% of original activities after exposure to full simulated digestive tract conditions for 6 h. All four enzymes proved to be particularly acid sensitive and only two products were enteric coated. The products demonstrated varying ability to hydrolyze lactose under simulated digestive tract conditions. The most effective product hydrolyzed 2.7 g lactose per capsule, suggesting that consumption of several capsules, as opposed to the usually recommended one or two, would be required to hydrolyze the entire 12 g lactose load characteristic of a dairy-based meal. All enzymes were substantially pure and displayed similar kinetic properties and molecular weights. None appeared ideally suited for use in the alleviation of lactose intolerance. The findings may in part explain the variability and often disappointing results previously reported for lactase-based clinical trials and will provide comparative baseline data against which candidate second-generation lactases may be assessed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16943638     DOI: 10.1385/abab:134:2:179

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  4 in total

1.  Nano-coating of beta-galactosidase onto the surface of lactose by using an ultrasound-assisted technique.

Authors:  Natalja Genina; Heikki Räikkönen; Jyrki Heinämäki; Peep Veski; Jouko Yliruusi
Journal:  AAPS PharmSciTech       Date:  2010-05-29       Impact factor: 3.246

Review 2.  Improving the stability and activity of oral therapeutic enzymes-recent advances and perspectives.

Authors:  Gregor Fuhrmann; Jean-Christophe Leroux
Journal:  Pharm Res       Date:  2013-11-02       Impact factor: 4.200

Review 3.  Challenges and perspectives of the β-galactosidase enzyme.

Authors:  B I S Damin; F C Kovalski; J Fischer; J S Piccin; A Dettmer
Journal:  Appl Microbiol Biotechnol       Date:  2021-07-05       Impact factor: 4.813

4.  Optimization and partial purification of beta-galactosidase production by Aspergillus niger isolated from Brazilian soils using soybean residue.

Authors:  Raquel Dall'Agnol Martarello; Luana Cunha; Samuel Leite Cardoso; Marcela Medeiros de Freitas; Damaris Silveira; Yris Maria Fonseca-Bazzo; Mauricio Homem-de-Mello; Edivaldo Ximenes Ferreira Filho; Pérola Oliveira Magalhães
Journal:  AMB Express       Date:  2019-06-10       Impact factor: 3.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.